Skip to content

Uroflow Measurements in Healthy Volunteers

Uroflow Measurements in Healthy Volunteers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00714389
Enrollment
12
Registered
2008-07-14
Start date
2008-02-29
Completion date
2008-03-31
Last updated
2013-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Urogynecology

Brief summary

The goal of this study to determine normal values for certain urinary measurements in order to better understand voiding dysfunction in women.

Detailed description

see above

Interventions

None listed

Sponsors

University of Rochester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers/employees * Normal voiding function. * Willing to participate.

Exclusion criteria

* Subjects currently receiving treatment for any lower urinary tract condition or having any voiding difficulty.

Design outcomes

Primary

MeasureTime frameDescription
Voided VolumeMarch 2008Volume of spontaneous void
Maximal Flow RateMarch 2008Maximal uroflow of spontaneous subject voids

Countries

United States

Participant flow

Recruitment details

Urogynecology and OBGYN clinic March 2008

Participants by arm

ArmCount
Spontaneous Uroflow Measurements
Spontaneous voids of subjects were recorded using uroflowmetry.
12
Total12

Baseline characteristics

CharacteristicSpontaneous Uroflow Measurements
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Age Continuous50 years
STANDARD_DEVIATION 10
Region of Enrollment
United States
12 participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Maximal Flow Rate

Maximal uroflow of spontaneous subject voids

Time frame: March 2008

ArmMeasureValue (MEAN)Dispersion
Spontaneous Uroflow MeasurementsMaximal Flow Rate49 mL/secStandard Deviation 16
Primary

Voided Volume

Volume of spontaneous void

Time frame: March 2008

ArmMeasureValue (MEAN)Dispersion
Spontaneous Uroflow MeasurementsVoided Volume306 mLStandard Deviation 148

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026